Its been almost a year since IPO and we haven't heard much from the BOD.
We have the COO (Peter) and the in-house counsel (Lior) resign and we have had a series of underwhelming announcements. (Buying a clinic with minimal patients, launching a CBD brand with low sales, low/ zero revenue on each consecutive 4C, launch into Asia with no sales etc etc)
All i can say, is expect nothing and hope for the best.
@Bgall2519 seems to be the biggest/ only supporter of this stock so I a sure he is close to the action - perhaps he can offer some clues as to what this company plans to do to generate revenue growth.
As it is currently 80% below the IPO price, one can only suspect that there is nothing of any substance going on here.
CAU Price at posting:
8.4¢ Sentiment: None Disclosure: Held
